BioSpace News Archive

Researchers May Have Unlocked Mechanism Driving Inflammation in Rheumatoid Arthritis

Researchers at Hokkaido University in Japan, in a collaboration with American scientists, may have unlocked the mechanism that drives widespread inflammation in inflammatory diseases.

May 18, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Drug Development

Capsida, Adverum, Instil and Metagenomi Showcase Therapies at ASGCT (Updated)

The American Society of Gene and Cell Therapy annual meeting continues to see companies showcasing promising therapeutics for multiple disease indications.

May 18, 2022
·
4 min read
·
Alex Keown
Business

Warren Buffet’s Latest Moves Reflect Biopharma Market Woes

Possibly reflecting the current Bear market, Berkshire Hathaway has walked away from its stake in both AbbVie and BMS.

May 18, 2022
·
2 min read
·
Alex Keown
Business

Flagship Pioneering Launches Microenvironment-Focused Sonata Therapeutics (Updated)

Flagship Pioneering announced the launch of Sonata Therapeutics. The fledgling company was created by combining two Flagship companies, Inzen Therapeutics and Cygnal Therapeutics.

May 18, 2022
·
3 min read
·
Mark Terry
Policy

Report: Pfizer, NIH Discussing Study of Longer Paxlovid Dosing Regimen

Following reports that Pfizer has declined study requests for Paxlovid, the company and NIH are said to be in conversation about potential studies assessing a longer treatment period of the antiviral.

May 18, 2022
·
2 min read
·
Alex Keown
Money on the Move: SwanBio, Remix, Locus, Mirvie and More

Recent funding saw support for a platform that selectively degrades DNA, software to help read mammograms and a company using corn genetics to develop cancer-targeting viruses.

May 18, 2022
·
8 min read
·
Hannah Chudleigh
The Highest Paying Life Science Jobs in 2022

BioSpace surveyed thousands of industry professionals to get the most current, accurate salary statistics. Read on to find out the top-paying jobs in each sector.

May 18, 2022
·
2 min read
·
Rosemary Scott
Drug Development

Global Roundup: Prota’s Immunotherapy Shows Success Against Peanut Allergy

In a Phase IIb study, data showed that Prota Therapeutics’ oral immunotherapy led to 51% of children reaching clinical remission of their peanut allergy compared to placebo. See inside for this and more!

May 18, 2022
·
8 min read
·
Alex Keown
Drug Development

Spruce Biosciences Aims to Break Through in CAH, PCOS

Spruce Biosciences is developing what could be the first new therapy treating congenital adrenal hyperplasia (CAH) since the 1960s, and a new therapy for women with polycystic ovary syndrome.

May 18, 2022
·
4 min read
·
Gail Dutton
Policy

Greece Goes After Novartis for Alleged Bribery and Kickbacks

Greece’s Health Minister Thanos Plevris announced plans to sue Novartis over what he alleges are illegal practices. In addition to demanding compensation, the country is implementing a three-point plan.

May 18, 2022
·
4 min read
·
Mark Terry